Pui-Wah Tse - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pui-Wah Tse

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

The Journal of Clinical Investigation|April 11, 2017

Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.

Cell Death & Disease|December 11, 2019

Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathwayDavid Kung-Chun Chiu, Aki Pui-Wah Tse, Cheuk-Ting Law, et al.

Nature Communications|February 18, 2022

Hypoxia-induced macropinocytosis represents a metabolic route for liver cancerMisty Shuo Zhang, Jane Di Cui, Derek Lee, et al.

Cellular and Molecular Gastroenterology and Hepatology|March 9, 2023

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver CancerJacinth Wing-Sum Cheu, Derek Lee, Qidong Li, et al.

Hepatology (Baltimore, Md.)|February 23, 2021

Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen SpeciesDerek Lee, Misty Shuo Zhang, Felice Ho-Ching Tsang, et al.

Oncogenesis|May 26, 2018

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancerAki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.

Hepatology (Baltimore, Md.)|July 23, 2014

Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinomaCarmen Chak-Lui Wong, Aki Pui-Wah Tse, Yan-Ping Huang, et al.

Journal of Hepatology|December 1, 2022

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responsesVincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.

Cell Reports|January 27, 2021

Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancerMacus Hao-Ran Bao, Chunxue Yang, Aki Pui-Wah Tse, et al.

Hepatology (Baltimore, Md.)|December 19, 2018

Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular CarcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.

Pageof 3

Search research articles

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

The Journal of Clinical Investigation|April 11, 2017

Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.

Cell Death & Disease|December 11, 2019

Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathwayDavid Kung-Chun Chiu, Aki Pui-Wah Tse, Cheuk-Ting Law, et al.

Nature Communications|February 18, 2022

Hypoxia-induced macropinocytosis represents a metabolic route for liver cancerMisty Shuo Zhang, Jane Di Cui, Derek Lee, et al.

Cellular and Molecular Gastroenterology and Hepatology|March 9, 2023

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver CancerJacinth Wing-Sum Cheu, Derek Lee, Qidong Li, et al.

Hepatology (Baltimore, Md.)|February 23, 2021

Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen SpeciesDerek Lee, Misty Shuo Zhang, Felice Ho-Ching Tsang, et al.

Oncogenesis|May 26, 2018

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancerAki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.

Hepatology (Baltimore, Md.)|July 23, 2014

Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinomaCarmen Chak-Lui Wong, Aki Pui-Wah Tse, Yan-Ping Huang, et al.

Journal of Hepatology|December 1, 2022

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responsesVincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.

Cell Reports|January 27, 2021

Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancerMacus Hao-Ran Bao, Chunxue Yang, Aki Pui-Wah Tse, et al.

Hepatology (Baltimore, Md.)|December 19, 2018

Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular CarcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.

Pageof 3